2 terminated, 1 unknown. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 2, Unknown 1 |
Follow TBR-760: new trials by email Literature Review of TBR-760 trials Research Report on TBR-760
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TBR-760 in Adult Patients With Non-Functioning Pituitary Adenomas TBR-760, Placebo - Non-Functional Pituitary Adenoma, Pituitary Tumor, Nonfunctioning | Phase 2 | Unknown | Tiburio Therapeutics | 150 | 2020-05-01 | 2020-04-06 |
| Study to Assess the Efficacy and Safety of Different Doses of BIM 23A760 in Patients With Carcinoid Syndrome BIM 23A760 - Carcinoid Syndrome | Phase 2 | Terminated | Ipsen | 8 | 2010-02-01 | 2020-11-20 |
| Study to Assess the Efficacy and Safety of Repeated Administration of BIM 23A760 in Patients With Acromegaly BIM 23A760 - Acromegaly | Phase 2 | Terminated | Ipsen | 109 | 2009-10-01 | 2019-11-22 |
Acromegaly (1) · Pituitary Neoplasms (1) · Serotonin Syndrome (1)
Ipsen (2) · Tiburio Therapeutics (1)
Belgium (2) · Czechia (2) · France (2) · Latvia (2) · Netherlands (2) · Poland (2) · Sweden (2) · Ukraine (2) · Austria (1) · Brazil (1) · Finland (1) · Germany (1) · Ireland (1) · Israel (1) · Italy (1)
2009 (2)